Apotex Corp. is voluntarily recalling 55,620 bottles of Guanfacine Extended-Release Tablets 2 mg because they may contain trace amounts of Quetiapine Fumarate, a different medication. Guanfacine (Intuniv) is typically used to treat ADHD, while Quetiapine Fumarate (Seroquel) is an antipsychotic medication. Consuming an unintended drug can lead to serious side effects and interactions. These affected 100-count bottles were distributed nationwide across the United States.
The presence of trace amounts of Quetiapine Fumarate in a Guanfacine product poses a risk of drug-to-drug interactions and unexpected side effects such as sedation, dizziness, or more severe reactions depending on the patient's health. No specific injuries or adverse events have been reported in this data, but the contamination represents a failure in manufacturing quality control.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.